In vivo cell reprogramming. A major step forward in regenerative medicine

Cell reprogramming  is revolutionizing the biomedical world, not only because it can obtain cells of different tissues from pluripotent cells, but also because these cells can be genetically modified to be used for the treatment of serious illnesses or to better understand them,...

Regenerative medicine. A review of current findings from an ethical perspective

The field of action of regenerative medicine (RM) is growing daily. Indeed, we only have to look at the economic figures that it moves, with an estimated market value for 2020 of 61,000 million Euros. However, RM also has important ethical components, not only related with the...

Adult stem cells could effectively substitute embryonic cells in regenerative medicine

Many technics showed that adult stem cells could effectively substitute embryonic cells in cellular therapy. One medical and ethical problem to resolve is to find adequate substitute for the use of embryonic stem cells in regenerative and reparatory medicine. The best possibility...

Parthenogenesis. A new possibility for regenerative medicine and a new bioethical dilemma

Parthenogenesis have allowed pluripotent stem cells to be obtained from oocytes (eggs) which have been stimulated to divide without having been fertilised by sperm. Can individuals be obtained from parthenogenesis? What is a partenote? Introduction A recent sentence from the...

Cord blood use in regenerative medicine

Everyone is aware of the importance of umbilical cord blood cells  , and especially the importance that they could have in the future in regenerative and reparatory medicine. Cells from cord blood use in regenerative medicine is very useful but, one problem at present it that...

Embryonic stem cells in regenerative medicine

A major issue associated to the use of embryonic stem cells in regenerative medicine is their tendency to induce tumour formation in the transplant receiver due to their undifferentiated state. This does not seem to happen when adult cells are used, however. In a recent letter...
Posted On 30 Dec 2013
, By

Pluripotent stem cells used for regenrative medicine risks. They can develop mutations that favor the production of cancer cells

It should be crucial to check pluripotent cell lines (embryonic and iPS cells) before clinical testing before their use in regenerative medicine The production of pluripotent stem cells, from which virtually all types of cells can be obtained, may be of great use for the...

Reproductive medicine and the production of bioartificial organs

Reproductive medicine and the production of bioartificial organs may be a source of hope in the next few years for patients with degenerative lesions of various organs, among them the reproductive organs. Undoubtedly, in this respect, major advances in stem cell knowledge,...
Posted On 12 May 2017
, By

Trachea transplants. Medical and ethical assessment of Paolo Macchiarini’s experiments

An interesting article was published recently in “The American Journal of Bioethics” (read HERE), that gives a brief history of the controversial trachea transplants performed by Paolo Macchiarini and his co-workers (see HERE) our previous news about the case)....

FDA wins major victory in campaign against stem cell clinics that marketing bogus and potentially hazardous products

One bioethical issue our Observatory is following is the proliferation of clinics offering stem cell treatments, many of which do not meet the necessary quality requirements. We published our first article on this problem in 2017 (see HERE and also North America’s two cell...